TIGIT and neoplasm: This suggests that co-blockade of PD-1 and CTLA-4 facilitates the entire process of T cells from activation to exercise of effector functions, whereas co-blockade of PD-1 and TIGIT provides enhanced tumor killing by activated T cells.